Opendata, web and dolomites


Precise brain oxygen monitoring for high-risk preterm infants

Total Cost €


EC-Contrib. €






 OXYPREM project word cloud

Explore the words cloud of the OXYPREM project. It provides you a very rough idea of what is the project "OXYPREM" about.

spectroscopy    head    off    intensive    born    reliability    near    world    nirs    silicone    urgent    impairment    brain    tissue    capitalizing    435    disabilities    die    levels    algorithms    therapy    oxyprem    ag    opportunity    preterms    spin    chronic    life    62    supply    oxygen    decrease    adults    opposed    precision    immature    oximeters    reusable    neurodevelopment    quality    reducing    lacking    swiss    actual    billion    easier    neonatal    paralysis    damage    sensor    commercialization    compelling    grow    neonatologists    oxygenation    shown    2024    created    business    babies    translates    zurich    deaths    medical    variations    viability    alerting    initially    transforming    prototypes    ones    preterm    variation    care    fixed    answer    designed    worth    competitors    disposable    annually    company    biocompatible    clinical    infrared    5x    respiratory    15    globally    signals    meant    running    cardiovascular    market    irreversible    savings    global    million    cagr2017    surviving    oximeter    monitor    degree    little    university    unnecessary    saturation    o2    consists    unmet   

Project "OXYPREM" data sheet

The following table provides information about the project.


Organization address
city: ZURICH
postcode: 8091
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2020-02-29


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OXYPREM AG CH (ZURICH) coordinator 50˙000.00


 Project objective

Globally, 15 million preterm babies are born annually (435,000 in Europe), from which 1 million die. Even when surviving, they may face disabilities, such as neurodevelopment impairment or paralysis. Since their respiratory and cardiovascular systems are immature, they need early oxygen (O2) therapy. Tissue oximeters are medical devices needed to monitor the actual level of O2 supply in their brain, since little O2 variations can produce irreversible damage. However, current devices are adapted from tissue oximeters initially meant for adults, lacking the precision and reliability preterm babies need. World leading neonatologists have been alerting about the urgent need to develop tissue oximeters specifically designed for preterms, to decrease unnecessary deaths and chronic disabilities. OxyPrem is our answer: a brain oximeter created just for preterm babies and providing the degree of precision and reliability they need. OxyPrem consists of (1) a high-quality Near-Infrared Spectroscopy (NIRS) sensor embedded in biocompatible silicone that is fixed to the preterm's head to monitor brain O2-levels, and a (2) monitor running advanced analysis algorithms transforming the signals into tissue oxygenation saturation measurements. OxyPrem prototypes have shown unmet levels of precision in clinical studies, reducing 5x the variation observed with competitors. Furthermore, our reusable sensor (opposed to the disposable ones from competitors), translates into important savings. OxyPrem represents a compelling business opportunity, capitalizing from the global neonatal intensive care market, worth €5.6 billion and expected to grow at a CAGR2017-2024 of 5.62%. The commercialization of OxyPrem is key to the viability of our company OxyPrem AG, a Swiss spin-off from University of Zurich, born to make preterm life's easier.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OXYPREM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OXYPREM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

HAC (2019)


Read More  

HUD (2018)


Read More